Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk
- PMID: 24908248
- PMCID: PMC4074274
- DOI: 10.1038/ng.3004
Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk
Abstract
Glioma, the most common central nervous system cancer in adults, has poor prognosis. Here we identify a new SNP associated with glioma risk, rs1920116 (near TERC), that reached genome-wide significance (Pcombined = 8.3 × 10(-9)) in a meta-analysis of genome-wide association studies (GWAS) of high-grade glioma and replication data (1,644 cases and 7,736 controls). This region has previously been associated with mean leukocyte telomere length (LTL). We therefore examined the relationship between LTL and both this new risk locus and other previously established risk loci for glioma using data from a recent GWAS of LTL (n = 37,684 individuals). Alleles associated with glioma risk near TERC and TERT were strongly associated with longer LTL (P = 5.5 × 10(-20) and 4.4 × 10(-19), respectively). In contrast, risk-associated alleles near RTEL1 were inconsistently associated with LTL, suggesting the presence of distinct causal alleles. No other risk loci for glioma were associated with LTL. The identification of risk alleles for glioma near TERC and TERT that also associate with telomere length implicates telomerase in gliomagenesis.
Figures


References
-
- Stupp R, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10:459–66. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 CA139020/CA/NCI NIH HHS/United States
- R01CA126831/CA/NCI NIH HHS/United States
- U58DP003862-01/DP/NCCDPHP CDC HHS/United States
- HHSN261201000140C/CA/NCI NIH HHS/United States
- P50 CA108961/CA/NCI NIH HHS/United States
- RC1NS068222Z/NS/NINDS NIH HHS/United States
- R25 CA112355/CA/NCI NIH HHS/United States
- R01 CA126831/CA/NCI NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- P50 CA097257/CA/NCI NIH HHS/United States
- UL1RR024131/RR/NCRR NIH HHS/United States
- P30CA15083/CA/NCI NIH HHS/United States
- UL1 TR000004/TR/NCATS NIH HHS/United States
- R01 CA052689/CA/NCI NIH HHS/United States
- BHF_/British Heart Foundation/United Kingdom
- RC1 NS068222/NS/NINDS NIH HHS/United States
- R25CA112355/CA/NCI NIH HHS/United States
- P30 CA015083/CA/NCI NIH HHS/United States
- HHSN261201000035I/CA/NCI NIH HHS/United States
- P50CA097257/CA/NCI NIH HHS/United States
- HHSN261201000035C/PC/NCI NIH HHS/United States
- HHSN261201000034C/CA/NCI NIH HHS/United States
- P50CA108961/CA/NCI NIH HHS/United States
- R01CA139020/CA/NCI NIH HHS/United States
- R01CA52689/CA/NCI NIH HHS/United States
- U58 DP003862/DP/NCCDPHP CDC HHS/United States
- WT_/Wellcome Trust/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources